Editorial
doi: 10.1056/NEJMe1307415.Inhibition of leukocyte trafficking in inflammatory bowel disease
- PMID:23964940
- DOI: 10.1056/NEJMe1307415
Item in Clipboard
Editorial
Inhibition of leukocyte trafficking in inflammatory bowel disease
Fabio Cominelli. N Engl J Med..
Display options
Format
Display options
Format
No abstract available
Comment on
- Vedolizumab as induction and maintenance therapy for ulcerative colitis.Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J, Parikh A; GEMINI 1 Study Group.Feagan BG, et al.N Engl J Med. 2013 Aug 22;369(8):699-710. doi: 10.1056/NEJMoa1215734.N Engl J Med. 2013.PMID:23964932Clinical Trial.
- Vedolizumab as induction and maintenance therapy for Crohn's disease.Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group.Sandborn WJ, et al.N Engl J Med. 2013 Aug 22;369(8):711-21. doi: 10.1056/NEJMoa1215739.N Engl J Med. 2013.PMID:23964933Clinical Trial.
Similar articles
- Vedolizumab for ulcerative colitis and Crohn's disease: results and implications of GEMINI studies.Lam MC, Bressler B.Lam MC, et al.Immunotherapy. 2014;6(9):963-71. doi: 10.2217/imt.14.66.Immunotherapy. 2014.PMID:25341118Clinical Trial.
- The role of integrin antagonists in the treatment of inflammatory bowel disease.Beniwal-Patel P, Saha S.Beniwal-Patel P, et al.Expert Opin Biol Ther. 2014 Dec;14(12):1815-23. doi: 10.1517/14712598.2014.967209. Epub 2014 Oct 7.Expert Opin Biol Ther. 2014.PMID:25288228Review.
- Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study.Stallmach A, Langbein C, Atreya R, Bruns T, Dignass A, Ende K, Hampe J, Hartmann F, Neurath MF, Maul J, Preiss JC, Schmelz R, Siegmund B, Schulze H, Teich N, von Arnim U, Baumgart DC, Schmidt C.Stallmach A, et al.Aliment Pharmacol Ther. 2016 Dec;44(11-12):1199-1212. doi: 10.1111/apt.13813. Epub 2016 Oct 7.Aliment Pharmacol Ther. 2016.PMID:27714831
- [Intestine selective therapy].Maronde U.Maronde U.MMW Fortschr Med. 2015 Jul 23;157(13):80. doi: 10.1007/s15006-015-3366-x.MMW Fortschr Med. 2015.PMID:26206050German.No abstract available.
- Vedolizumab for the treatment of ulcerative colitis.Shahidi N, Bressler B, Panaccione R.Shahidi N, et al.Expert Opin Biol Ther. 2016;16(1):129-35. doi: 10.1517/14712598.2016.1121231. Epub 2015 Dec 9.Expert Opin Biol Ther. 2016.PMID:26567768Review.
Cited by
- Vedolizumab in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Safety, Efficacy, and Place of Therapy.Takatsu N, Hisabe T, Higashi D, Ueki T, Matsui T.Takatsu N, et al.Core Evid. 2020 Apr 1;15:7-20. doi: 10.2147/CE.S179053. eCollection 2020.Core Evid. 2020.PMID:32280316Free PMC article.Review.
- Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn's Disease-Like Ileitis: What is the Right Model?Cominelli F, Arseneau KO, Rodriguez-Palacios A, Pizarro TT.Cominelli F, et al.Cell Mol Gastroenterol Hepatol. 2017 Mar 6;4(1):19-32. doi: 10.1016/j.jcmgh.2017.02.010. eCollection 2017 Jul.Cell Mol Gastroenterol Hepatol. 2017.PMID:28560286Free PMC article.Review.
- Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn's disease?Gilroy L, Allen PB.Gilroy L, et al.Clin Exp Gastroenterol. 2014 May 22;7:163-72. doi: 10.2147/CEG.S45261. eCollection 2014.Clin Exp Gastroenterol. 2014.PMID:24899819Free PMC article.Review.
- Mycobiota in gastrointestinal diseases.Mukherjee PK, Sendid B, Hoarau G, Colombel JF, Poulain D, Ghannoum MA.Mukherjee PK, et al.Nat Rev Gastroenterol Hepatol. 2015 Feb;12(2):77-87. doi: 10.1038/nrgastro.2014.188. Epub 2014 Nov 11.Nat Rev Gastroenterol Hepatol. 2015.PMID:25385227Review.
- Targeting leukocyte trafficking for the treatment of inflammatory bowel disease.Arseneau KO, Cominelli F.Arseneau KO, et al.Clin Pharmacol Ther. 2015 Jan;97(1):22-8. doi: 10.1002/cpt.6. Epub 2014 Dec 2.Clin Pharmacol Ther. 2015.PMID:25670380Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical